A potentially more effective treatment for HER2 mutant metastatic breast cancer
A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read MoreA phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read More